Texas A&M Volleyball

Morrison & Co. are amped up to host marquee matchup vs. Wisconsin

Following a 3-1 win over fourth-ranked Stanford, head coach Jamie Morrison joined us on Friday's edition of TexAgs Live to discuss what "clicked" for Texas A&M. Morrison also previewed tonight's marquee matchup at Reed Arena vs. No. 6 Wisconsin.
By David Nuño
September 11, 2026
1.6k Views
Discuss
Story Poster
Photo by Danny Grant, TexAgs
Free Preview
Watch the full version by becoming a Premium subscriber.
Try Premium for $1
No Thanks
Trial available for new subscribers only.

Key notes from Jamie Morrison interview

  • I want to thank TexAgs for believing in our program and covering volleyball. It meant a lot that Kay Naegeli came to Florida to watch us. We love the support we have had from TexAgs.
     
  • We are just getting started. I said it at the end of last year. I said it again this year. The amount of investment from TexAgs, the administration and the 12th Man has been incredible.
To watch the full version of this video feature, you must be a TexAgs Premium subscriber.
Try Premium for $1
See Subscription Benefits →
Trial only available to users who have never subscribed or participated in a previous trial
Discuss
Tags
Jamie Morrison TexAgs Live Kay Naegeli TexAgs Live Feature Kelly Sheffield Texas A&M vs. Stanford Texas A&M vs. Wisconsin Kyndal Stowers Volleyball Texas A&M Wisconsin Stanford
Show All
Missouri State 2026
More Volleyball
See All →
Photo Gallery: 9,211 pack Reed for top-20 showdown
By Daniel Grant
Game Highlights: Five-set war slips away from A&M
By Andrew Wu
Improving Aggies fall just short vs. No. 6 Badgers
By Grace Nichter
Rapid Reaction: Ags end up on the wrong side of a five-set thriller
By Kay Naegeli
Discussion from...

Morrison & Co. are amped up to host marquee matchup vs. Wisconsin

735 Views | 0 Replies | Last: 2 days ago by David Nuño
There are not any replies to this post yet.
Refresh
Page 1 of 1
 
×
subscribe Verify your student status
See Subscription Benefits
Trial only available to users who have never subscribed or participated in a previous trial.